The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements.

Consumer staples thrive as investors brace for economic uncertainty. Retailers Costco, Dollar General, and Target posted gains along with the wider sector.

In Tuesday afternoon trading, 144 stocks hit 52-week lows, while 86 hit 52-week highs. Most of the 52-week lows were on the Nasdaq. Here are two that look very enticing.

As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.

Health insurers UnitedHealth, Humana, and Elevance pay steady dividends, offering stability even as the industry faces headwinds regarding Medicaid coverage.

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

Tech giants Apple and Microsoft declined in August on weak revenue guidance, but Federal Reserve rate hikes are also playing a role in a broad-market pullback.

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

These two high-potential healthcare names bring a rare opportunity for investors to gain some exposure to quality businesses trading at a discount to industry